Pharmacotherapy of depression and bipolar disorder Flashcards
Drug interactions with antidepressants
MAO-Is, serotonin syndrome may result
Prototype SSRIs
Fluoxetine (Prozac), Sertaline (Zoloft)
MOA of SSRIs
blocks 5-HT reuptake, increased neurotransmitter in cleft
Therapeutic use of SSRIs
MDD, anxiety
Pharmacokinetics of SSRIs
First pass metabolism, active metabolites
well absorbed
requires 5-6 weeks to reach steady state
complete wash out in 5-6 weeks
Side effects of SSRIs
initial anxiety
agitation
sexual dysfunction
Toxicity of SSRIs
agitation, vomiting, seizure
pregnancy C-persistant pulmonary hypertension in newborns
Drug interactions with SSRIs
Inhibits CYP 2D6- Tomoxifen for breast cancer
Drugs that prolong QT interval
Advantages of sertraline
better tolerated, widely prescribed
Prototyped SNRI
Duloxetine (cymbalta)
MOA of SNRI
both seratonin and norepinephrine reuptake inhibited
Therapeutic use of SNRI
MDD
anxiety
some types of chronic pain
Pharmacokinetics of duloxetine
Well absorbed-food slows absorption
metabolixed by 2D6
half life 11-12 hrs
Side effects of duloxetine
headache, somnolence, fatigue, insomnia
nausea, dry mouth, constipation, diarrhea
some chance of liver damage
Drug interactions of duloxetine
Drugs using NET for their action- methyldopa, monoxidil
CYP 1A2 and 2D6 inhibitors
MAO inhibitors- seretonin syndrome